Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1064.0% | +1245.1% | 3 / 3 | +289.5% | +99.16 pp | +434.74 pp | +137.3% | 1.93 | 9.89 | 1,0 | +289,5% | 3,0 | +1.064,0% | 9.89 | -9.37 | — |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 12 | -4 | 8 | |||||||
Valuation annotation:Price: 5.900 (close price on 2026-10-19)EPS (TTM): 596,6
Financial charts
1.Revenue & growth
VND bn0,96Q2/26
1.Revenue & growth
VND bn0,96Q2/26
2.Profit & growth
VND bn2,97Q2/26
3.Profit mix (Penman)
VND bn10,3Q2/26
4.Margins & cost structure
%13.8%Q2/26
5.Returns & cash cycle
% · days0.5%Q2/26
6.Earnings quality & cash
VND bn85,7Q2/26
7.Asset structure
VND bn34,4Q2/26
8.Funding & debt health
VND bn · times34,4Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %9,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %171Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26